Pagina 3 - I migliori medici per il trattamento di Rectal cancer - TOP-97 medici

Dr. Alemdar specializes in medical oncology with a focus on personalized treatment plans for rectal cancer patients.

• Graduated from Kocaeli University Faculty of Medicine
• Specialized in Medical Oncology at Akdeniz University
• Extensive experience in hospitals across Turkey
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Thomas Mansfeld specializes in laparoscopic colorectal surgery, offering minimally invasive solutions for rectal cancer at Asklepios Hospital Barmbek.

• Senior Consultant in Gastrointestinal Medicine at Asklepios Hospital
• Expert in laparoscopic ('keyhole') surgery techniques
• Member of the European Board of Surgeons
• Special focus on complex abdominal wall reconstructions

Prof. Ozcan Yildiz is a Senior Medical Oncologist with extensive academic and clinical experience in gastrointestinal cancers.

• Over 10 years of research and clinical practice in neuroendocrine and GI tumors
• Specialized focus on complex tumor presentations and paraneoplastic syndromes
• Authored numerous studies on rare gastrointestinal malignancies
• Skilled in managing chemotherapy side effects and uncommon complications

Dr. Topcu specializes in rectal cancer treatment with international training at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center.

• Medical oncology specialist with 15+ years of experience
• Trained at top cancer centers in the USA and Canada
• Works with various gastrointestinal cancers including rectal cancer
• Member of Karadeniz Technical University Faculty of Medicine

Professor Michele Reni coordinates Italy's pancreatic cancer treatment guidelines and has published 180+ cancer research papers.

• 30+ years specializing in digestive system cancers
• Leads the Pancreas Center at San Raffaele Hospital
• Chairs clinical trials for metastatic pancreatic cancer
• Board-certified in both radiation and clinical oncology

Dr. Fox leads treatment at a certified interdisciplinary cancer center, combining chemotherapy, immunotherapy, and molecular diagnostics for rectal cancer.

• Specialized in haematology, oncology, and immunology since 2011
• Chief Physician at BKZ Solingen’s certified cancer center
• Active in molecular biology research for innovative treatments
• Member of American Association for Cancer Research

Associate Professor Tahsin Ozatli specializes in gastrointestinal cancers, including rectal cancer, with years of dedicated practice.

• Trained at Selcuk University Faculty of Medicine
• Experienced in oncology departments across Turkey
• Promoted to Associate Professor in 2016

Professor Keil specializes in diagnostic and interventional radiology for rectal cancer, using advanced imaging techniques like MRI and CT.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Deepened expertise under renowned Professor Rolf W. Günther at University Hospital Aachen
• Chief Physician of Diagnostic and Interventional Radiology at Academic Hospital Solingen
• Specializes in cross-sectional imaging and full-range interventional radiology

Assoc. Prof. Nail Paksoy specializes in rectal cancer treatment at Medipol Bahçelievler Hospital, bringing extensive oncology expertise and research involvement.

• Board-certified in Medical Oncology by ESMO
• Active participant in international clinical trials for colorectal cancer
• Published multiple studies on gastrointestinal cancers
• Fellowship-trained at Istanbul University Oncology Institute

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Associate Professor Babek Tabandeh specializes in minimally invasive cancer surgery, including rectal cancer procedures at Medical Park Göztepe Hospital.

• Over 25 years of experience in general surgery
• Member of the American College of Surgeons
• Author of 40+ medical documents
• Faculty member at Bahçeşehir University

Professor Gul Alco specializes in radiation oncology for rectal cancer at Medipol Acibadem District Hospital, with over 20 years of experience.

• Professor at Istanbul Medipol University – one of Turkey's leading medical schools
• Fellowship-trained in radiation oncology at Kadir Has University
• Member of the Turkish Radiation Oncology Society
• Practices at Medipol Acibadem District Hospital – a JCI-accredited facility

Dr. Ercan Ozden trained at prestigious Istanbul University and specializes in medical oncology with a focus on rectal cancer.

• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of internal medicine experience
• Practiced at multiple reputable hospitals in Turkey
• Graduated from Istanbul University's English Medical Program

With over 20 years of experience, Dr. Muzaffer Al brings specialized laparoscopic techniques to rectal cancer treatment.

• Trained in advanced laparoscopic surgery at Istanbul University
• Focused on both oncological cancer and bariatric surgery
• Specialized in laparoscopic antireflux procedures

Dr. Alon Pikarsky brings over 25 years of surgical expertise to rectal cancer treatment at Hadassah Medical Center.

• Specializes in colorectal surgery with extensive academic and clinical roles
• Board-certified in general surgery since 1998
• Director of surgical residency programs since 2000
• Senior lecturer in surgery since 2005

Honor graduate from Hacettepe University, specializing in nutrition for cancer patients and post-bariatric surgery care.

• Conducted research on the relationship between nutrition and chronic diseases
• Interned at top hospitals including Hacettepe University Oncology Hospital
• Completed specialized courses in bariatric nutrition and obesity
• Works with diverse patient groups including cancer and diabetes patients

Dr. Joseba Rebollo Liceaga brings over 30 years of oncology experience, specializing in rectal cancer at Quironsalud Torrevieja.

• Head of Oncology at Clínica San Miguel de Navarra for 13 years
• Authored research on electrochemotherapy and multidisciplinary treatments
• Specialist in Medical Oncology from Clínica Universidad de Navarra
• Associate Physician at University of Navarra's Faculty of Medicine

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.